Articles

A transdermal patch, Lidoderm (lidocaine 5 percent) appears to provide significant improvement in both pain intensity and pain relief for patients with painful diabetic neuropathy.

Risk of stroke increases significantly as body mass index (BMI) increases.

54% of women with gestational diabetes mellitus (GDM) report never having been told they were at increased risk for developing type 2 diabetes in later life.

Omega-3 fatty acid intake is shown to be associated with reduced risk of coronary heart disease (CHD) in women, and of sudden death in men, in two new reports released last week.

Studies suggest that homocysteine may elevate blood pressure and increase the risk of hypertension.

Subclinical inflammation was shown to be a strong predictor of cardiovascular events and was suggested to be a part of the metabolic syndrome (MS).

Elevations of HBP in the morning in diabetic patients are strongly related to microvascular and macrovascular complications.

Treatment with fluorquinolones in doses commonly prescribed in routine clinical practice is associated with a reduction in the risk of coronary heart diseases among patients with type 2 diabetes.

Timing is critical in the optimal use of short-acting insulin secretagogues

Israel’s Keryx Biopharmaceuticals is shepherding a drug through the final stages of U.S. clinical trials that can reduce albumin levels and gives hope to the three to four million U.S. diabetes sufferers who experience kidney failure along with their diabetes.